Oriental Aromatics Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: May 31, 2025, 8:52 pm

Market Cap	1,217 Cr.
Current Price	362
High / Low	657/252
Stock P/E	35.4
Book Value	197
Dividend Yield	0.14 %
ROCE	7.87 %
ROE	5.30 %
Face Value	5.00
PEG Ratio	-2.23

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Oriental Aromatics Ltd

Competitors of Oriental Aromatics Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Gujchem Distillers India Ltd	140 Cr.	394	541/195		390	0.00 %	1.38 %	2.17 %	1.00
Elantas Beck India Ltd	7,706 Cr.	9,720	14,980/8,150	56.9	1,094	0.08 %	23.0 %	17.4 %	10.0
Crestchem Ltd	55.8 Cr.	186	350/120	20.4	24.9	0.27 %	59.3 %	44.1 %	10.0
Chemiesynth (Vapi) Ltd	11.0 Cr.	35.8	0.00/0.00		35.8	0.00 %	2.99 %	0.99 %	10.0
Archit Organosys Ltd	87.6 Cr.	42.7	61.0/34.2	17.4	33.7	0.00 %	10.8 %	7.57 %	10.0
Industry Average	5,478.08 Cr	1,765.63		45.08	333.76	0.30%	14.08%	10.74%	7.41

All Competitor Stocks of Oriental Aromatics Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	202.87	233.55	220.76	199.42	195.34	195.69	226.82	197.41	216.48	215.76	236.77	222.57	253.16
Expenses	180.72	217.13	206.19	185.39	186.16	194.76	215.81	183.30	195.60	193.65	208.15	200.02	233.89
Operating Profit	22.15	16.42	14.57	14.03	9.18	0.93	11.01	14.11	20.88	22.11	28.62	22.55	19.27
OPM %	10.92%	7.03%	6.60%	7.04%	4.70%	0.48%	4.85%	7.15%	9.65%	10.25%	12.09%	10.13%	7.61%
Other Income	2.26	2.03	2.35	0.61	0.74	0.57	2.81	2.16	1.74	1.69	2.10	0.09	0.24
Interest	2.69	2.40	3.32	4.16	3.15	4.60	5.46	6.87	3.43	4.06	6.34	6.36	8.62
Depreciation	4.62	4.67	4.81	4.98	4.97	4.81	4.94	4.96	5.08	4.89	5.16	6.40	7.23
Profit before tax	17.10	11.38	8.79	5.50	1.80	-7.91	3.42	4.44	14.11	14.85	19.22	9.88	3.66
Tax %	38.71%	26.10%	27.99%	30.91%	33.89%	-23.64%	29.24%	41.22%	28.28%	26.13%	23.10%	27.73%	60.93%
Net Profit	10.48	8.41	6.34	3.80	1.19	-6.05	2.42	2.61	10.12	10.98	14.78	7.14	1.42
EPS in Rs	3.11	2.50	1.88	1.13	0.35	-1.80	0.72	0.78	3.01	3.26	4.39	2.12	0.42

Last Updated: May 31, 2025, 8:13 am

Below is a detailed analysis of the quarterly data for Oriental Aromatics Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 253.16 Cr.. The value appears strong and on an upward trend. It has increased from 222.57 Cr. (Dec 2024) to 253.16 Cr., marking an increase of 30.59 Cr..
For Expenses, as of Mar 2025, the value is 233.89 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 200.02 Cr. (Dec 2024) to 233.89 Cr., marking an increase of 33.87 Cr..
For Operating Profit, as of Mar 2025, the value is 19.27 Cr.. The value appears to be declining and may need further review. It has decreased from 22.55 Cr. (Dec 2024) to 19.27 Cr., marking a decrease of 3.28 Cr..
For OPM %, as of Mar 2025, the value is 7.61%. The value appears to be declining and may need further review. It has decreased from 10.13% (Dec 2024) to 7.61%, marking a decrease of 2.52%.
For Other Income, as of Mar 2025, the value is 0.24 Cr.. The value appears strong and on an upward trend. It has increased from 0.09 Cr. (Dec 2024) to 0.24 Cr., marking an increase of 0.15 Cr..
For Interest, as of Mar 2025, the value is 8.62 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.36 Cr. (Dec 2024) to 8.62 Cr., marking an increase of 2.26 Cr..
For Depreciation, as of Mar 2025, the value is 7.23 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.40 Cr. (Dec 2024) to 7.23 Cr., marking an increase of 0.83 Cr..
For Profit before tax, as of Mar 2025, the value is 3.66 Cr.. The value appears to be declining and may need further review. It has decreased from 9.88 Cr. (Dec 2024) to 3.66 Cr., marking a decrease of 6.22 Cr..
For Tax %, as of Mar 2025, the value is 60.93%. The value appears to be increasing, which may not be favorable. It has increased from 27.73% (Dec 2024) to 60.93%, marking an increase of 33.20%.
For Net Profit, as of Mar 2025, the value is 1.42 Cr.. The value appears to be declining and may need further review. It has decreased from 7.14 Cr. (Dec 2024) to 1.42 Cr., marking a decrease of 5.72 Cr..
For EPS in Rs, as of Mar 2025, the value is 0.42. The value appears to be declining and may need further review. It has decreased from 2.12 (Dec 2024) to 0.42, marking a decrease of 1.70.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 3:17 pm

Metric	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	458	506	755	760	709	873	854	842	892
Expenses	400	441	639	633	553	780	799	795	797
Operating Profit	57	65	116	127	156	93	54	47	94
OPM %	13%	13%	15%	17%	22%	11%	6%	6%	11%
Other Income	6	-0	-2	7	1	4	6	7	6
Interest	5	7	13	12	2	4	13	20	20
Depreciation	14	15	18	19	17	17	19	20	22
Profit before tax	44	43	83	103	137	76	27	14	58
Tax %	37%	42%	31%	16%	26%	30%	28%	35%
Net Profit	28	25	57	86	102	53	20	9	43
EPS in Rs	13.54	7.43	16.98	25.61	30.29	15.84	5.87	2.70	12.78
Dividend Payout %	3%	7%	6%	10%	8%	9%	9%	18%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-10.71%	128.00%	50.88%	18.60%	-48.04%	-62.26%	-55.00%
Change in YoY Net Profit Growth (%)	0.00%	138.71%	-77.12%	-32.27%	-66.64%	-14.22%	7.26%

Oriental Aromatics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2017-2018 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	4%
3 Years:	2%
TTM:	10%

Compounded Profit Growth
10 Years:	%
5 Years:	-17%
3 Years:	-14%
TTM:	276%

Stock Price CAGR
10 Years:	17%
5 Years:	19%
3 Years:	-12%
1 Year:	5%

Return on Equity
10 Years:	%
5 Years:	7%
3 Years:	3%
Last Year:	5%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 7:56 pm

Month	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	5	8	17	17	17	17	17	17	17
Reserves	311	329	375	447	540	588	608	616	640
Borrowings	105	132	183	51	78	140	231	206	250
Other Liabilities	69	103	98	93	110	120	130	157	163
Total Liabilities	490	573	673	608	745	865	986	995	1,069
Fixed Assets	211	212	245	236	236	265	273	270	295
CWIP	15	40	1	2	13	25	53	173	192
Investments	0	0	0	0	0	0	0	0	0
Other Assets	264	321	428	370	496	574	661	551	582
Total Assets	490	573	673	608	745	865	986	995	1,069

Below is a detailed analysis of the balance sheet data for Oriental Aromatics Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is 17.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 17.00 Cr..
For Reserves, as of Sep 2024, the value is 640.00 Cr.. The value appears strong and on an upward trend. It has increased from 616.00 Cr. (Mar 2024) to 640.00 Cr., marking an increase of 24.00 Cr..
For Borrowings, as of Sep 2024, the value is 250.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 206.00 Cr. (Mar 2024) to 250.00 Cr., marking an increase of 44.00 Cr..
For Other Liabilities, as of Sep 2024, the value is 163.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 157.00 Cr. (Mar 2024) to 163.00 Cr., marking an increase of 6.00 Cr..
For Total Liabilities, as of Sep 2024, the value is 1,069.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 995.00 Cr. (Mar 2024) to 1,069.00 Cr., marking an increase of 74.00 Cr..
For Fixed Assets, as of Sep 2024, the value is 295.00 Cr.. The value appears strong and on an upward trend. It has increased from 270.00 Cr. (Mar 2024) to 295.00 Cr., marking an increase of 25.00 Cr..
For CWIP, as of Sep 2024, the value is 192.00 Cr.. The value appears strong and on an upward trend. It has increased from 173.00 Cr. (Mar 2024) to 192.00 Cr., marking an increase of 19.00 Cr..
For Investments, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Other Assets, as of Sep 2024, the value is 582.00 Cr.. The value appears strong and on an upward trend. It has increased from 551.00 Cr. (Mar 2024) to 582.00 Cr., marking an increase of 31.00 Cr..
For Total Assets, as of Sep 2024, the value is 1,069.00 Cr.. The value appears strong and on an upward trend. It has increased from 995.00 Cr. (Mar 2024) to 1,069.00 Cr., marking an increase of 74.00 Cr..

Notably, the Reserves (640.00 Cr.) exceed the Borrowings (250.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	16	-23	181	17	-1	-22	142
Cash from Investing Activity +	-31	-12	-10	-35	-59	-46	-99
Cash from Financing Activity +	15	36	-159	16	51	78	-48
Net Cash Flow	0	0	12	-2	-9	9	-5

Free Cash Flow

Month	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-48.00	-67.00	-67.00	76.00	78.00	-47.00	-177.00	-159.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	80	97	77	73	97	81	81	78
Inventory Days	141	148	149	124	211	183	233	177
Days Payable	41	68	39	43	66	52	55	52
Cash Conversion Cycle	180	177	187	154	242	213	259	203
Working Capital Days	166	163	166	130	194	190	223	169
ROCE %		11%	19%	21%	24%	12%	5%	4%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	74.17%	74.17%	74.17%	74.17%	74.17%	74.17%	74.17%	74.17%	74.17%	74.17%	74.17%	74.17%
FIIs	0.11%	0.14%	0.14%	0.13%	0.13%	0.13%	0.11%	0.10%	0.10%	0.10%	0.05%	0.08%
DIIs	0.64%	0.76%	0.76%	0.76%	0.78%	0.75%	0.61%	0.39%	0.39%	0.00%	0.00%	0.00%
Public	25.09%	24.93%	24.92%	24.92%	24.91%	24.96%	25.11%	25.34%	25.33%	25.72%	25.78%	25.76%
No. of Shareholders	28,415	28,338	29,029	28,579	27,024	26,561	26,730	26,545	25,875	25,715	25,898	27,213

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
PGIM India Small Cap Fund	190,192	0.46	6.71	190,192	2025-04-22 15:56:55	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	5.00	5.00	5.00	5.00	5.00
Basic EPS (Rs.)	2.71	5.87	15.84	30.29	25.61
Diluted EPS (Rs.)	2.71	5.87	15.84	30.29	25.61
Cash EPS (Rs.)	8.59	11.64	20.89	35.48	31.26
Book Value[Excl.RevalReserv]/Share (Rs.)	187.90	185.70	179.84	165.59	137.92
Book Value[Incl.RevalReserv]/Share (Rs.)	187.90	185.70	179.84	165.59	137.92
Revenue From Operations / Share (Rs.)	248.53	252.30	258.16	210.63	225.80
PBDIT / Share (Rs.)	16.11	17.81	28.80	46.57	39.77
PBIT / Share (Rs.)	10.23	12.04	23.75	41.38	34.12
PBT / Share (Rs.)	4.18	8.17	22.55	40.70	30.58
Net Profit / Share (Rs.)	2.71	5.87	15.84	30.29	25.61
NP After MI And SOA / Share (Rs.)	2.71	5.87	15.84	30.29	25.61
PBDIT Margin (%)	6.48	7.05	11.15	22.11	17.61
PBIT Margin (%)	4.11	4.77	9.19	19.64	15.11
PBT Margin (%)	1.68	3.23	8.73	19.32	13.54
Net Profit Margin (%)	1.08	2.32	6.13	14.38	11.34
NP After MI And SOA Margin (%)	1.08	2.32	6.13	14.38	11.34
Return on Networth / Equity (%)	1.43	3.15	8.80	18.29	18.56
Return on Capital Employeed (%)	4.80	5.88	11.76	23.74	23.22
Return On Assets (%)	0.91	2.00	6.16	13.68	14.16
Long Term Debt / Equity (X)	0.08	0.05	0.07	0.00	0.00
Total Debt / Equity (X)	0.32	0.36	0.23	0.13	0.09
Asset Turnover Ratio (%)	0.84	0.91	1.08	1.05	1.19
Current Ratio (X)	1.90	2.15	2.99	3.02	3.18
Quick Ratio (X)	0.90	0.91	1.45	1.58	1.76
Inventory Turnover Ratio (X)	1.65	1.93	2.39	2.13	2.66
Dividend Payout Ratio (NP) (%)	18.48	0.00	9.47	8.25	13.66
Dividend Payout Ratio (CP) (%)	5.82	0.00	7.17	7.04	11.19
Earning Retention Ratio (%)	81.52	0.00	90.53	91.75	86.34
Cash Earning Retention Ratio (%)	94.18	0.00	92.83	92.96	88.81
Interest Coverage Ratio (X)	2.66	4.60	23.96	67.83	11.22
Interest Coverage Ratio (Post Tax) (X)	1.45	2.52	14.18	45.12	8.23
Enterprise Value (Cr.)	1198.42	1395.23	2504.87	2032.54	474.66
EV / Net Operating Revenue (X)	1.43	1.64	2.88	2.87	0.62
EV / EBITDA (X)	22.10	23.28	25.84	12.97	3.55
MarketCap / Net Operating Revenue (X)	1.20	1.39	2.73	2.79	0.59
Retention Ratios (%)	81.51	0.00	90.52	91.74	86.33
Price / BV (X)	1.59	1.89	3.92	3.54	0.97
Price / Net Operating Revenue (X)	1.20	1.39	2.73	2.79	0.59
EarningsYield	0.01	0.01	0.02	0.05	0.19

After reviewing the key financial ratios for Oriental Aromatics Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 5.00.
For Basic EPS (Rs.), as of Mar 24, the value is 2.71. This value is below the healthy minimum of 5. It has decreased from 5.87 (Mar 23) to 2.71, marking a decrease of 3.16.
For Diluted EPS (Rs.), as of Mar 24, the value is 2.71. This value is below the healthy minimum of 5. It has decreased from 5.87 (Mar 23) to 2.71, marking a decrease of 3.16.
For Cash EPS (Rs.), as of Mar 24, the value is 8.59. This value is within the healthy range. It has decreased from 11.64 (Mar 23) to 8.59, marking a decrease of 3.05.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 187.90. It has increased from 185.70 (Mar 23) to 187.90, marking an increase of 2.20.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 187.90. It has increased from 185.70 (Mar 23) to 187.90, marking an increase of 2.20.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 248.53. It has decreased from 252.30 (Mar 23) to 248.53, marking a decrease of 3.77.
For PBDIT / Share (Rs.), as of Mar 24, the value is 16.11. This value is within the healthy range. It has decreased from 17.81 (Mar 23) to 16.11, marking a decrease of 1.70.
For PBIT / Share (Rs.), as of Mar 24, the value is 10.23. This value is within the healthy range. It has decreased from 12.04 (Mar 23) to 10.23, marking a decrease of 1.81.
For PBT / Share (Rs.), as of Mar 24, the value is 4.18. This value is within the healthy range. It has decreased from 8.17 (Mar 23) to 4.18, marking a decrease of 3.99.
For Net Profit / Share (Rs.), as of Mar 24, the value is 2.71. This value is within the healthy range. It has decreased from 5.87 (Mar 23) to 2.71, marking a decrease of 3.16.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 2.71. This value is within the healthy range. It has decreased from 5.87 (Mar 23) to 2.71, marking a decrease of 3.16.
For PBDIT Margin (%), as of Mar 24, the value is 6.48. This value is below the healthy minimum of 10. It has decreased from 7.05 (Mar 23) to 6.48, marking a decrease of 0.57.
For PBIT Margin (%), as of Mar 24, the value is 4.11. This value is below the healthy minimum of 10. It has decreased from 4.77 (Mar 23) to 4.11, marking a decrease of 0.66.
For PBT Margin (%), as of Mar 24, the value is 1.68. This value is below the healthy minimum of 10. It has decreased from 3.23 (Mar 23) to 1.68, marking a decrease of 1.55.
For Net Profit Margin (%), as of Mar 24, the value is 1.08. This value is below the healthy minimum of 5. It has decreased from 2.32 (Mar 23) to 1.08, marking a decrease of 1.24.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 1.08. This value is below the healthy minimum of 8. It has decreased from 2.32 (Mar 23) to 1.08, marking a decrease of 1.24.
For Return on Networth / Equity (%), as of Mar 24, the value is 1.43. This value is below the healthy minimum of 15. It has decreased from 3.15 (Mar 23) to 1.43, marking a decrease of 1.72.
For Return on Capital Employeed (%), as of Mar 24, the value is 4.80. This value is below the healthy minimum of 10. It has decreased from 5.88 (Mar 23) to 4.80, marking a decrease of 1.08.
For Return On Assets (%), as of Mar 24, the value is 0.91. This value is below the healthy minimum of 5. It has decreased from 2.00 (Mar 23) to 0.91, marking a decrease of 1.09.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.08. This value is below the healthy minimum of 0.2. It has increased from 0.05 (Mar 23) to 0.08, marking an increase of 0.03.
For Total Debt / Equity (X), as of Mar 24, the value is 0.32. This value is within the healthy range. It has decreased from 0.36 (Mar 23) to 0.32, marking a decrease of 0.04.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.84. It has decreased from 0.91 (Mar 23) to 0.84, marking a decrease of 0.07.
For Current Ratio (X), as of Mar 24, the value is 1.90. This value is within the healthy range. It has decreased from 2.15 (Mar 23) to 1.90, marking a decrease of 0.25.
For Quick Ratio (X), as of Mar 24, the value is 0.90. This value is below the healthy minimum of 1. It has decreased from 0.91 (Mar 23) to 0.90, marking a decrease of 0.01.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.65. This value is below the healthy minimum of 4. It has decreased from 1.93 (Mar 23) to 1.65, marking a decrease of 0.28.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 18.48. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 18.48, marking an increase of 18.48.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 5.82. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 5.82, marking an increase of 5.82.
For Earning Retention Ratio (%), as of Mar 24, the value is 81.52. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 81.52, marking an increase of 81.52.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 94.18. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 94.18, marking an increase of 94.18.
For Interest Coverage Ratio (X), as of Mar 24, the value is 2.66. This value is below the healthy minimum of 3. It has decreased from 4.60 (Mar 23) to 2.66, marking a decrease of 1.94.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.45. This value is below the healthy minimum of 3. It has decreased from 2.52 (Mar 23) to 1.45, marking a decrease of 1.07.
For Enterprise Value (Cr.), as of Mar 24, the value is 1,198.42. It has decreased from 1,395.23 (Mar 23) to 1,198.42, marking a decrease of 196.81.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.43. This value is within the healthy range. It has decreased from 1.64 (Mar 23) to 1.43, marking a decrease of 0.21.
For EV / EBITDA (X), as of Mar 24, the value is 22.10. This value exceeds the healthy maximum of 15. It has decreased from 23.28 (Mar 23) to 22.10, marking a decrease of 1.18.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.20. This value is within the healthy range. It has decreased from 1.39 (Mar 23) to 1.20, marking a decrease of 0.19.
For Retention Ratios (%), as of Mar 24, the value is 81.51. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 81.51, marking an increase of 81.51.
For Price / BV (X), as of Mar 24, the value is 1.59. This value is within the healthy range. It has decreased from 1.89 (Mar 23) to 1.59, marking a decrease of 0.30.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.20. This value is within the healthy range. It has decreased from 1.39 (Mar 23) to 1.20, marking a decrease of 0.19.
For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Oriental Aromatics Ltd as of June 1, 2025 is: 296.10

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 1, 2025, Oriental Aromatics Ltd is Overvalued by 18.20% compared to the current share price 362.00

Intrinsic Value of Oriental Aromatics Ltd as of June 1, 2025 is: 249.16

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 1, 2025, Oriental Aromatics Ltd is Overvalued by 31.17% compared to the current share price 362.00

Last 5 Year EPS CAGR: -15.85%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has higher reserves (494.89 cr) compared to borrowings (152.89 cr), indicating strong financial stability. The company has shown consistent growth in sales (738.78 cr) and profit (65.00 cr) over the years.	The stock has a low average ROCE of 12.00%, which may not be favorable. The stock has a high average Working Capital Days of 175.13, which may not be favorable. The stock has a high average Cash Conversion Cycle of 201.88, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Oriental Aromatics Ltd:
1. Net Profit Margin: 1.08%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 4.8% (Industry Average ROCE: 14.08%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 1.43% (Industry Average ROE: 10.74%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 1.45
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.9
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 35.4 (Industry average Stock P/E: 45.08)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.32
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Oriental Aromatics Ltd. is a Public Limited Listed company incorporated on 29/03/1961 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L17299MH1972PLC285731 and registration number is 285731. Currently Company is involved in the business activities of Manufacture of synthetic aromatic products. Company's Total Operating Revenue is Rs. 927.97 Cr. and Equity Capital is Rs. 16.83 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Chemicals - Organic - Others	133 Jehangir Building, 2nd Floor, Mumbai Maharashtra 400001	investors@orientalaromatics.com http://www.orientalaromatics.com

Management
Name	Position Held
Mr. Dharmil A Bodani	Chairman & Managing Director
Mr. Ranjit A Puranik	Independent Director
Mr. Harshvardhan A Piramal	Independent Director
Ms. Amruda V Nair	Independent Director
Mr. Prakash V Mehta	Independent Director
Mr. Shyamal A Bodani	Executive Director
Mr. Satish K Ray	Executive Director - Operations

FAQ

What is the intrinsic value of Oriental Aromatics Ltd?

Oriental Aromatics Ltd's intrinsic value (as of 01 June 2025) is ₹296.10 — 18.20% lower the current market price of 362.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 1,217 Cr. market cap, FY2025-2026 high/low of ₹657/252, reserves of 640 Cr, and liabilities of 1,069 Cr.

What is the Market Cap of Oriental Aromatics Ltd?

The Market Cap of Oriental Aromatics Ltd is 1,217 Cr..

What is the current Stock Price of Oriental Aromatics Ltd as on 01 June 2025?

The current stock price of Oriental Aromatics Ltd as on 01 June 2025 is 362.

What is the High / Low of Oriental Aromatics Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Oriental Aromatics Ltd stocks is ₹657/252.

What is the Stock P/E of Oriental Aromatics Ltd?

The Stock P/E of Oriental Aromatics Ltd is 35.4.

What is the Book Value of Oriental Aromatics Ltd?

The Book Value of Oriental Aromatics Ltd is 197.

What is the Dividend Yield of Oriental Aromatics Ltd?

The Dividend Yield of Oriental Aromatics Ltd is 0.14 %.

What is the ROCE of Oriental Aromatics Ltd?

The ROCE of Oriental Aromatics Ltd is 7.87 %.

What is the ROE of Oriental Aromatics Ltd?

The ROE of Oriental Aromatics Ltd is 5.30 %.

What is the Face Value of Oriental Aromatics Ltd?

The Face Value of Oriental Aromatics Ltd is 5.00.